Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
149 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer
Condition: Endometrial Neoplasm
Intervention: Procedure: Sentinel lymph node mapping
2 Recruiting Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Drug: Paclitaxel;   Drug: MLN0128;   Drug: MLN1117
3 Recruiting Sentinel Lymph Node Detection in Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel node procedure
4 Recruiting Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel lymph node biopsy
5 Recruiting The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Procedure: TH;   Procedure: TH/BSO;   Procedure: BPLND
6 Recruiting Serum Biomarkers in Diagnosis and Predicting Prognosis of Endometrial and Ovarian Cancers
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Intervention: Diagnostic Test: TFF3, SFRP4, Romo1, NFKB
7 Recruiting STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Extraperitoneal Laparoscopic aortic lymphadenectomy;   Procedure: Transperitoneal Laparoscopic aortic lymphadenectomy
8 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
9 Recruiting Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Conditions: Uterine Neoplasms;   Endometrial Neoplasms
Intervention:
10 Recruiting Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
Conditions: Lynch Syndrome;   Endometrial Neoplasms;   Ovarian Neoplasms;   Colorectal Neoplasms
Intervention: Behavioral: Questionnaire, Educational Material
11 Not yet recruiting Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Blind biopsy with a pipette;   Procedure: Targeted biopsy using hysteroscopy
12 Not yet recruiting Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: ONC201
13 Recruiting Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors
Conditions: Endometrium Cancer;   Life Style;   Obesity
Intervention: Behavioral: Intervention group
14 Not yet recruiting An Endometrial Cancer Study of Sodium Cridanimod in Conjunction With Progestin Therapy
Condition: Endometrial Cancer
Interventions: Drug: Sodium Cridanimod;   Drug: progestin therapy
15 Not yet recruiting Evaluation of the Fluorescent Green of Indocyanine in the Detection of Sentinel Lymph Node in Endometrial Cancer
Condition: Cancer of the Endometrium
Intervention:
16 Not yet recruiting Study of Niraparib in Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Niraparib
17 Recruiting Endometrial Cancer Diet and Exercise
Condition: Early Stage Endometrial Cancer
Intervention: Behavioral: Home-based aerobic exercise and nutritional counseling
18 Recruiting Study of Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer
Condition: Metastatic Endometrial Cancer
Intervention: Drug: Avelumab
19 Recruiting Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Condition: Recurrent Endometrial Cancer
Intervention: Drug: Pembrolizumab
20 Not yet recruiting Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells.
Condition: Progesterone Induced Blocking Factor in Endometrial Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.